NeuroPath Biosciences is a pioneering health-tech company dedicated to transforming the future of mental health science.
We combine biochemical research with digital assessment to create the first objective tools for detecting emotional distress the biological state that precedes anxiety, depression, or self-harm risk.
Our mission is to bridge biology and mental health, enabling earlier, evidence-based support and improving outcomes for individuals and healthcare providers alike.
We are committed to advancing a world where emotional wellbeing can be measured, understood, and supported through science-driven care.
Mental health today is read from a single, noisy input- how a person happens to present in a ten-minute appointment. Signals get missed, and risk stays invisible until crisis.
NeuroPath brings the signals together. We combine biochemical measurement, a digital check-in, and AI to turn multiple noisy inputs into one clear, objective signal a clinician can act on.
Our vision is mental health assessment that is objective, preventative, and stigma-free care that begins earlier, before crisis.
Our Mission and Core Values
At NeuroPath Biosciences, we are committed to advancing mental health science. Our mission is to improve the lives of individuals affected by self-harm and related conditions by developing objective diagnostic tools that enable earlier, evidence-based care.
Bringing measurement where mental health assessment has relied on judgement alone.
Translating established science into clinical practice, aligned to NICE NG225, not hype.
Clinican led
Built to fit the routine appointment. No new workflow, no added time.
Earlier, before crisis
Detecting distress sooner, so care can begin before the point of crisis.